VKTX has a lipid drug they are developing in Phase 2 that appears to be better than MDGL lipid drug in Phase 2 , and VKTX only has about 10 million more in O/S shares yet MDGL is trading at 16.00 + and they do not even have anything close to VKTX other Blockbuster drug VK5211. VKTX has a better drug Pipeline by far ...
VKTX is undervalued !!!
So the question is why is VKTX at 1.25 and MDGL at 16.00 !!!!